Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France

Pediatric Infectious Disease Journal

Volumn 17, Issue 8, 1998, Pages 705-710

  Wallon, Martine ^a   Caudie, Christiane ^b   Rubio, Sophie ^a   Bellini, Lydia ^a   Girault, Véronique ^a   Gay Andrieu, Françoise ^a   Peyron, François ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Cerebrospinal fluid; Congenital toxoplasmosis; Diagnosis

Indexed keywords

FANSIDAR; FOLINIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE;

ANTIBODY TITER; ARTICLE; BRAIN CALCIFICATION; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CHORIORETINITIS; CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL DISEASE; ORAL DRUG ADMINISTRATION; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII;

EID: 0031812955     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199808000-00009     Document Type: Article

References (18)

1. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765-9.
2. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serological screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1858-63.
3. Couvreur J, Thulliez Ph, Daffos F, et al. Foetopathie toxoplasmique: traitement in utero par l'association pyriméthamine-sulfamides. Arch Fr Pediatr 1991;38:63-8.
4. Couvreur J, Desmonts G, Tournier G, Collin F, Saint-Joigny G, Leprince C. La production locale accrue d'immunoglobulines spécifiques G dans le liquide céphalo-rachidien au cours de la toxoplasmose congénitale. Ann Pediatr 1984;31:829-35.
5. Roizen N, Swischer CN, Stein MA, et al. Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995;95:11-20.
6. Bazard MC, Becker A, Berrod JP, Raspiller A. La choriorétinite toxoplasmique congénitale. J Fr Ophtalmol 1990;13: 434-40.
7. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO,eds. Infectious diseases of the fetus and the newborn infant. 3rd ed. Philadelphia: Saunders, 1990:89-195.
8. Ferret N, Marty P, Tordjman C, et al. La toxoplasmose dans les Alpes-Maritimes: a propos de 26 cas observés entre 1984 et 1990. Pédiatrie 1992;47:467-71.
9. Alford CA, Foft JW, Blankenship WJ, Cassady G, Benton JW. Subclinical central nervous system disease of neonates: a prospective study of infants born with increased levels of IgM. J Pediatr 1969;75:1167-78.
10. Alford CA Jr, Stagno S, Reynolds DW. Congenital toxoplasmosis: clinical, laboratory and therapeutic considerations with special reference to subclinical disease. Bull NY Acad Med 1974;50:160-81.
11. Neuenschwander S, Cordier MD, Couvreur J. Toxoplasmose congénitale: apport de l'échotomographie transfontanellaire et de la tomodensitométrie. Ann Pediatr 1984;31:837-9.
12. Desmonts G, Couvreur J. L'isolement du parasite dans la toxoplasmose congénitale: intérêt pratique et théorique. Arch Fr Pediatr 1974;31:157-66.
13. Gross U, Muller J, Roost T, Schrod L, Heesemann J. Possible reasons for failure of conventional tests for diagnosis of fatal congenital toxoplasmosis: report of a case diagnosed by PCR and immunoblot. Infection 1992;20:149-51.
14. Verhofstede C, Van Renterghem L, Plum J, Vanderschueren S, Vanhaesebrouck P. Congenital toxoplasmosis and TORCH. Lancet 1990;336:622-3.
15. Bonadio WA, Stanco L, Bruce R, Barry D, Smith D. Reference values of normal cerebrospinal fluid composition in infants aged 0 to 8 weeks. Infect Dis J 1992;38:63-8.
16. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: Saunders, 1980.
17. Wallon M, Gandilhon F, Peyron F, Mojon M. Toxoplasmose congénitale: estimation du risque de transmission maternofoetale en fonction de la date de la contamination maternelle. Presented at a meeting of Société Française de Parasitologie, Angers, France, May 23 to 24, 1995.
18. Peyron F, Wallon M, Bernardoux C. Long-term follow-up of congenital ocular toxoplasmosis. N Engl J Med 1996;334: 993-4.